Therapeutic potential of co-signaling receptor modulation in hepatitis B [scRNA-Seq]
Single-cell RNA-seq · mouse · 10 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Mus musculus (mouse)
- Samples
- 10 samples: 2 × CD8 T cells, HC_primed, d3, vs 2 × CD8 T cells, HC_primed, d5, vs 2 × CD8 T cells, HC_primed, d7, vs 2 × CD8 T cells, HC_primed, dGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Therapeutic potential of co-signaling receptor modulation in hepatitis BCell · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE240036_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1001959 and SRA study SRP453277. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 8 samples.
How we read this: 4 replicated groups read from 10 sample titles; they account for 8 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7680368 CD8 T cells, Naive
- GSM7680369 CD8 T cells, HC_primed, d3, rep1 CD8 T cells, HC_primed,…
- GSM7680370 CD8 T cells, HC_primed, d3, rep2 CD8 T cells, HC_primed,…
- GSM7680371 CD8 T cells, HC_primed, d5, rep1 CD8 T cells, HC_primed,…
- GSM7680372 CD8 T cells, HC_primed, d5, rep2 CD8 T cells, HC_primed,…
- GSM7680373 CD8 T cells, HC_primed, d7, rep1 CD8 T cells, HC_primed,…
- GSM7680374 CD8 T cells, HC_primed, d7, rep2 CD8 T cells, HC_primed,…
- GSM7680375 CD8 T cells, HC_primed, d14 CD8 T cells, HC_primed,…
- GSM7680376 CD8 T cells, HC_primed, d28 CD8 T cells, HC_primed,…
- GSM7680377 CD8 T cells, KC_primed, d28
- GSE311488 Chemotherapeutic Induction of Single-Stranded DNA Accumulation Sensitizes Triple-Negative Breast Cancer to Immunotherapy [scRNA-seq] 32 samples shares therapeutic, scrna-seq
- GSE308848 Targeting AEBP1 to mitigate pro-tumor activity of cancer-associated fibroblasts and increase therapeutic efficacy to anti-PD-1 [scRNA-Seq] 12 samples shares therapeutic, scrna-seq
- GSE298492 Macrophage-derived KIF13B acts as a potential therapeutic target in atherosclerosis by enhancing MERTK-mediated efferocytosis [RNA-Seq] 12 samples shares therapeutic, potential
- GSE268407 Cellular senescence in skeletal muscle aging: new mechanisms and therapeutic potential for sarcopenia 2 samples shares therapeutic, potential
- GSE305529 METTL3-Driven RNA Modifications: A Key Mechanism and Potential Therapeutic Target in Pancreatic Acinar Cell Carcinoma in Mice [MeRIP] 48 samples shares therapeutic, potential
- GSE307773 Oncogenic MAPK signalling induces epithelial cell state change and therapeutic resistance in vivo [RNA-Seq] 175 samples shares therapeutic
- GSE223323 Enterocyte like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability 148 samples shares therapeutic
- GSE288185 TDP-43 directly inhibits RNA accumulation in neurites through modulation of RNA stability 86 samples shares modulation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.